Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.

Malpani BL, Samuel AM, Ray S.

Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):535-40.

PMID:
8655377
2.

Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.

Bohuslavizki KH, Brenner W, Klutmann S, Hübner RH, Lassmann S, Feyerabend B, Lüttges J, Tinnemeyer S, Clausen M, Henze E.

J Nucl Med. 1998 Jul;39(7):1237-42.

3.

Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine.

Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tönshoff G, Sippel C, Wolf H, Clausen M, Henze E.

Nucl Med Commun. 1996 Aug;17(8):681-6.

PMID:
8878127
4.

The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.

Jentzen W, Balschuweit D, Schmitz J, Freudenberg L, Eising E, Hilbel T, Bockisch A, Stahl A.

Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2298-306. doi: 10.1007/s00259-010-1532-z. Epub 2010 Jul 13.

PMID:
20625723
5.

Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.

Bohuslavizki KH, Klutmann S, Jenicke L, Brenner W, Feyerabend B, Henze E, Clausen M.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):181-6.

PMID:
10477022
6.

Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Brenner W, Kröger S, Buchert R, Bleckmann C, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Nov;175 Suppl 4:6-12.

PMID:
10584133
7.

Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.

Jentzen W, Schneider E, Freudenberg L, Eising EG, Görges R, Müller SP, Brandau W, Bockisch A.

Nucl Med Commun. 2006 Aug;27(8):669-76.

PMID:
16829767
8.

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S.

J Nucl Med. 2005 Feb;46(2):261-6.

9.

Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.

Raza H, Khan AU, Hameed A, Khan A.

Nucl Med Commun. 2006 Jun;27(6):495-9.

PMID:
16710103
10.

[Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].

Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Kalina S, Clausen M, Henze E.

Nuklearmedizin. 1997 Apr;36(3):103-9. German.

PMID:
9162904
11.
12.
13.

Salivary gland scintigraphy after radioiodine therapy.

Malpani BL, Samuel AM, Jaiswar RK.

Nucl Med Commun. 1998 Feb;19(2):183-4. No abstract available.

PMID:
9548203
14.

Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.

Bohuslavizki KH, Klutmann S, Brenner W, Mester J, Henze E, Clausen M.

J Clin Oncol. 1998 Nov;16(11):3542-9.

PMID:
9817273
15.

Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance.

Loutfi I, Nair MK, Ebrahim AK.

J Nucl Med Technol. 2003 Jun;31(2):81-5.

17.

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Bleckmann C, Brenner W, Lassmann S, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Feb;175(2):57-61.

PMID:
10065139
18.

A kinetic compartment model for evaluating salivary gland scintigraphies.

Afzelius P, Fuglsang S.

Clin Physiol Funct Imaging. 2014 Mar;34(2):143-50. doi: 10.1111/cpf.12078. Epub 2013 Aug 1.

PMID:
23909953
19.

Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.

Wu JQ, Feng HJ, Ouyang W, Sun YG, Chen P, Wang J, Xian JL, Huang LH.

Nucl Med Commun. 2015 Aug;36(8):819-26. doi: 10.1097/MNM.0000000000000325.

PMID:
25932534
20.

Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.

Liu B, Huang R, Kuang A, Zhao Z, Zeng Y, Wang J, Tian R.

Med Phys. 2011 Oct;38(10):5412-9. doi: 10.1118/1.3602459.

PMID:
21992360

Supplemental Content

Support Center